DentalEZ selects Henry Schein as exclusive global distributor of Indentafi

September 24, 2012

Issue 9

MALVERN, Pa., Sept. 24, 2012 -- DentalEZ® Group today announced that it has signed a letter of intent to make Henry Schein, Inc. (NASDAQ:HSIC) the exclusive global distributor of the Identafi® Oral Cancer Screening Device, a product of the DentalEZ® Group's StarDental® Division.

MALVERN, Pa., Sept. 24, 2012 -- DentalEZ® Group today announced that it has signed a letter of intent to make Henry Schein, Inc. (NASDAQ:HSIC) the exclusive global distributor of the Identafi® Oral Cancer Screening Device, a product of the DentalEZ® Group's StarDental® Division.

Henry Schein is the world's largest provider of health care products and

services to office-based dental, medical and animal health practitioners.

Identafi will become a core component of Henry Schein Dental's Total™ 

Health Beyond The Mouth initiative.

 

The Identafi system is a small, cordless, handheld unit that is designed for

use in the offices of dentists, specialists and general practitioners to

screen for oral cancers and pre-cancers. Unlike other fluorescent

technologies and dye systems, the multi-spectral device uses a

three-wavelength optical illumination and visualization system that allows

dental professionals to identify biochemical and morphological changes in

cells of the mouth, throat, tongue and tonsils that are not visible to the

naked eye. The Indentafi Oral Cancer Screening Device received an Editor's

Choice award from The Dental Advisor, was named as one of the "Top 100

Products of 2012" by Dentistry Today, and was selected as the Gold Winner in

the dental instruments, equipment and supplies category of the 2012 Medical

Design Excellence Awards competition.

 

"We admire the active role that Henry Schein has taken to advocate for the

early screening of oral cancer, as well as their proven ability to build

market share for innovative products like the StarDental Identafi Oral

Cancer Screening Device," said Gordon Hagler, President and Chief Operating

Officer of DentalEZ Group.  "We look forward to the prospect of working with

Henry Schein exclusively to advance this important public health issue and

communicate the exceptional benefits of our system to dentists around the

world."

 

The Oral Cancer Foundation estimates that oral cancer kills one person every

hour, every day in the United States. However, when oral cancer is detected

early, patients have an 80 to 90 percent survival rate.

 

"The Indentafi Oral Cancer Screening Device will be an exciting new addition

to the industry leading solutions that we offer exclusively to our

customers," said Tim Sullivan, President of Henry Schein Dental.

 

"Henry Schein has been dedicated to the early detection of oral cancer for

many years.  We look forward to our new partnership with a renowned,

worldwide dental company such as DentalEZ Group, and working together to

expand our Total Health™ Beyond The Mouth initiative, which underscores

our steadfast commitment to help our dental customers provide the best and

most comprehensive care possible to patients," added Mr. Sullivan.

 

Henry Schein Dental's Total Health Beyond the Mouth initiative includes the

Total Health Checklist, which, together with screening and diagnostics,

assists dental professionals in assessing a patient's oral health, its

impact on their total health, and uncovering health problems.